Transthyretin Amyloidosis Treatment Market Size, Trends, Analysis, and Outlook By Treatment (Targeted Therapy, Supportive Therapy, Pipeline Therapy), By Type (ATTR-PN, ATTR-CM), By Disease (Hereditary Transthyretin Amyloidosis, Wild Type Amyloidosis), By Distribution Channel (Hospital Pharmacies, Specialty Pharmacies, Retail Pharmacies, Online Pharmacies), by Region, Country, Segment, and Companies, 2024-2030
The global Transthyretin Amyloidosis Treatment market size is poised to register 7.87% growth from 2024 to 2030, presenting significant growth prospects for companies operating in the industry. The industry study analyzes the global Transthyretin Amyloidosis Treatment market across By Treatment (Targeted Therapy, Supportive Therapy, Pipeline Therapy), By Type (ATTR-PN, ATTR-CM), By Disease (Hereditary Transthyretin Amyloidosis, Wild Type Amyloidosis), By Distribution Channel (Hospital Pharmacies, Specialty Pharmacies, Retail Pharmacies, Online Pharmacies).
The Transthyretin Amyloidosis Treatment Market is experiencing significant expansion driven by advancements in disease understanding and the development of targeted therapies aimed at stabilizing or reducing the production of amyloid fibrils. Key trends shaping its future include the emergence of novel small molecule and gene-silencing therapies targeting transthyretin (TTR) protein aggregation, the utilization of biomarkers for early disease detection and treatment monitoring, and the implementation of multidisciplinary care approaches involving genetic counseling, supportive therapies, and organ transplantation. Moreover, factors such as the increasing awareness of transthyretin amyloidosis and the growing pipeline of promising therapeutic candidates are expected to drive market growth in 2024 and beyond.
Transthyretin Amyloidosis Treatment Market Drivers, Trends, Opportunities, and Growth Opportunities
This comprehensive study discusses the latest trends and the most pressing challenges for industry players and investors. The Transthyretin Amyloidosis Treatment market research analyses the global market trends, key drivers, challenges, and opportunities in the industry. In addition, the latest Future of Transthyretin Amyloidosis Treatment survey report provides the market size outlook across types, applications, and other segments across the world and regions. It provides data-driven insights and actionable recommendations for companies in the Transthyretin Amyloidosis Treatment industry.
Key market trends defining the global Transthyretin Amyloidosis Treatment demand in 2024 and Beyond
The industry continues to remain an attractive hub for opportunities for both domestic and global vendors. As the market evolves, factors such as emerging market dynamics, demand from end-user sectors, a growing patient base, changes in consumption patterns, and widening distribution channels continue to play a major role.
Transthyretin Amyloidosis Treatment Market Segmentation- Industry Share, Market Size, and Outlook to 2030
The Transthyretin Amyloidosis Treatment industry comprises a wide range of segments and sub-segments. The rising demand for these product types and applications is supporting companies to increase their investment levels across niche segments. Accordingly, leading companies plan to generate a large share of their future revenue growth from expansion into these niche segments. The report presents the market size outlook across segments to support Transthyretin Amyloidosis Treatment companies scaling up production in these sub-segments with a focus on expanding into emerging countries.
Key strategies adopted by companies within the Transthyretin Amyloidosis Treatment industry
Leading Transthyretin Amyloidosis Treatment companies are boosting investments to capitalize on untapped potential and future possibilities across niche market segments and surging demand conditions in key regions. Further, companies are leveraging advanced technologies to unlock opportunities and achieve operational excellence. The report provides key strategies opted for by the top 10 Transthyretin Amyloidosis Treatment companies.
Transthyretin Amyloidosis Treatment Market Study- Strategic Analysis Review
The Transthyretin Amyloidosis Treatment market research report dives deep into the qualitative factors shaping the market, empowering you to make informed decisions-
The Transthyretin Amyloidosis Treatment industry report provides a detailed analysis and outlook of revenue generated by companies from 2018 to 2023. Further, with actual data for 2023, the report forecasts the market size outlook from 2024 to 2030 in three case scenarios- low case, reference case, and high case scenarios.
Transthyretin Amyloidosis Treatment Country Analysis and Revenue Outlook to 2030
The report analyses 22 countries worldwide including the key driving forces and market size outlook from 2021 to 2030. In addition, region analysis across Asia Pacific, Europe, the Middle East, Africa, North America, and South America is included in the study. For each of the six regions, the market size outlook by segments is forecast for 2030.
North America Transthyretin Amyloidosis Treatment Market Size Outlook- Companies plan for focused investments in a changing environment
The US continues to remain the market leader in North America, driven by a large consumer base, the presence of well-established providers, and a strong end-user industry demand. Leading companies focus on new product launches in the changing environment. The US economy is expected to grow in 2024 (around 2.2% growth in 2024), potentially driving demand for various Transthyretin Amyloidosis Treatment market segments. Similarly, Strong end-user demand is encouraging Canadian Transthyretin Amyloidosis Treatment companies to invest in niche segments. Further, as Mexico continues to strengthen its trade relations and invest in technological advancements, the Mexico Transthyretin Amyloidosis Treatment market is expected to experience significant expansion, offering lucrative opportunities for both domestic and international stakeholders.
Europe Transthyretin Amyloidosis Treatment Market Size Outlook-Companies investing in assessing consumers, categories, competitors, and capabilities
The German industry remains the major market for companies in the European Transthyretin Amyloidosis Treatment industry with consumers in Germany, France, the UK, Spain, Italy, and others anticipated to register a steady demand throughout the forecast period, driving the overall market prospects. In addition, the proactive approach of businesses in identifying and leveraging new growth prospects positions the European Transthyretin Amyloidosis Treatment market for an upward trajectory, fostering both domestic and international interest. Leading brands operating in the industry are emphasizing effective marketing strategies, innovative product offerings, and a keen understanding of consumer preferences.
Asia Pacific Transthyretin Amyloidosis Treatment Market Size Outlook- an attractive hub for opportunities for both local and global companies
The increasing prevalence of indications, robust healthcare expenditure, and increasing investments in healthcare infrastructure drive the demand for Transthyretin Amyloidosis Treatment in Asia Pacific. In particular, China, India, and South East Asian Transthyretin Amyloidosis Treatment markets present a compelling outlook for 2030, acting as a magnet for both domestic and multinational manufacturers seeking growth opportunities. Similarly, with a burgeoning population and a rising middle class, India offers a vast consumer market. Japanese and Korean companies are quickly aligning their strategies to navigate changes, explore new markets, and enhance their competitive edge. Our report utilizes in-depth interviews with industry experts and comprehensive data analysis to provide a comprehensive outlook of 6 major markets in the region.
Latin America Transthyretin Amyloidosis Treatment Market Size Outlook- Continued urbanization and rising income levels
Rising income levels contribute to greater purchasing power among consumers, spurring consumption and creating opportunities for market expansion. Continued urbanization and rising income levels are expected to sustainably drive consumption growth in the medium to long term.
Middle East and Africa Transthyretin Amyloidosis Treatment Market Size Outlook- continues its upward trajectory across segments
Robust demand from Middle Eastern countries including Saudi Arabia, the UAE, Qatar, Kuwait, and other GCC countries supports the overall Middle East Transthyretin Amyloidosis Treatment market potential. Fueled by increasing healthcare expenditure of individuals, growing population, and high prevalence across a few markets drives the demand for Transthyretin Amyloidosis Treatment.
Transthyretin Amyloidosis Treatment Market Company Profiles
The global Transthyretin Amyloidosis Treatment market is characterized by intense competitive conditions with leading companies opting for aggressive marketing to gain market shares. The report presents business descriptions, SWOT analysis, growth strategies, and financial profiles. Leading companies included in the study are Acrotech Biopharma, Alnylam Pharmaceuticals Inc, Astellas Pharma Inc, AstraZeneca, BridgeBio Pharma Inc, Bristol-Myers Squibb Company, Ionis Pharmaceuticals Inc, Johnson & Johnson Services Inc, Pfizer Inc, Prothena, SOM Biotech
Recent Transthyretin Amyloidosis Treatment Market Developments
The global Transthyretin Amyloidosis Treatment market study presents recent market news and developments including new product launches, mergers, acquisitions, expansions, product approvals, and other updates in the industry.
Transthyretin Amyloidosis Treatment Market Report Scope
Parameters: Revenue, Volume Price
Study Period: 2023 (Base Year); 2018- 2023 (Historic Period); 2024- 2030 (Forecast Period)
Currency: USD; (Upon request, can be provided in Euro, JPY, GBP, and other Local Currency)
Qualitative Analysis
By Treatment Therapy
Targeted Therapy
-Onpattro
-Inotersen
-Vyndaqel/Vyndamax
Supportive Therapy
Pipeline Therapy
By Type
ATTR-PN
ATTR-CM
By Disease Type
Hereditary Transthyretin Amyloidosis
-Polyneuropathy
-Cardiomyopathy
-Mixed Type
Wild Type Amyloidosis
By Distribution Channel
Hospital Pharmacies
Specialty Pharmacies
Retail Pharmacies
Online Pharmacies
Geographical Segmentation:
Acrotech Biopharma
Alnylam Pharmaceuticals Inc
Astellas Pharma Inc
AstraZeneca
BridgeBio Pharma Inc
Bristol-Myers Squibb Company
Ionis Pharmaceuticals Inc
Johnson & Johnson Services Inc
Pfizer Inc
Prothena
SOM Biotech
Formats Available: Excel, PDF, and PPT
The Transthyretin Amyloidosis Treatment Market is experiencing significant expansion driven by advancements in disease understanding and the development of targeted therapies aimed at stabilizing or reducing the production of amyloid fibrils. Key trends shaping its future include the emergence of novel small molecule and gene-silencing therapies targeting transthyretin (TTR) protein aggregation, the utilization of biomarkers for early disease detection and treatment monitoring, and the implementation of multidisciplinary care approaches involving genetic counseling, supportive therapies, and organ transplantation. Moreover, factors such as the increasing awareness of transthyretin amyloidosis and the growing pipeline of promising therapeutic candidates are expected to drive market growth in 2024 and beyond.
Transthyretin Amyloidosis Treatment Market Drivers, Trends, Opportunities, and Growth Opportunities
This comprehensive study discusses the latest trends and the most pressing challenges for industry players and investors. The Transthyretin Amyloidosis Treatment market research analyses the global market trends, key drivers, challenges, and opportunities in the industry. In addition, the latest Future of Transthyretin Amyloidosis Treatment survey report provides the market size outlook across types, applications, and other segments across the world and regions. It provides data-driven insights and actionable recommendations for companies in the Transthyretin Amyloidosis Treatment industry.
Key market trends defining the global Transthyretin Amyloidosis Treatment demand in 2024 and Beyond
The industry continues to remain an attractive hub for opportunities for both domestic and global vendors. As the market evolves, factors such as emerging market dynamics, demand from end-user sectors, a growing patient base, changes in consumption patterns, and widening distribution channels continue to play a major role.
Transthyretin Amyloidosis Treatment Market Segmentation- Industry Share, Market Size, and Outlook to 2030
The Transthyretin Amyloidosis Treatment industry comprises a wide range of segments and sub-segments. The rising demand for these product types and applications is supporting companies to increase their investment levels across niche segments. Accordingly, leading companies plan to generate a large share of their future revenue growth from expansion into these niche segments. The report presents the market size outlook across segments to support Transthyretin Amyloidosis Treatment companies scaling up production in these sub-segments with a focus on expanding into emerging countries.
Key strategies adopted by companies within the Transthyretin Amyloidosis Treatment industry
Leading Transthyretin Amyloidosis Treatment companies are boosting investments to capitalize on untapped potential and future possibilities across niche market segments and surging demand conditions in key regions. Further, companies are leveraging advanced technologies to unlock opportunities and achieve operational excellence. The report provides key strategies opted for by the top 10 Transthyretin Amyloidosis Treatment companies.
Transthyretin Amyloidosis Treatment Market Study- Strategic Analysis Review
The Transthyretin Amyloidosis Treatment market research report dives deep into the qualitative factors shaping the market, empowering you to make informed decisions-
- Industry Dynamics: Porter's Five Forces analysis to understand bargaining power, competitive rivalry, and threats that impact long-term strategy formulation.
- Strategic Insights: Provides valuable perspectives on key players and their approaches based on comprehensive strategy analysis.
- Internal Strengths and Weaknesses: Develop targeted strategies to leverage strengths, address weaknesses, and capitalize on market opportunities.
- Future Possibilities: Prepare for diverse outcomes with in-depth scenario analysis. Explore potential market disruptions, technology advancements, and economic changes.
The Transthyretin Amyloidosis Treatment industry report provides a detailed analysis and outlook of revenue generated by companies from 2018 to 2023. Further, with actual data for 2023, the report forecasts the market size outlook from 2024 to 2030 in three case scenarios- low case, reference case, and high case scenarios.
Transthyretin Amyloidosis Treatment Country Analysis and Revenue Outlook to 2030
The report analyses 22 countries worldwide including the key driving forces and market size outlook from 2021 to 2030. In addition, region analysis across Asia Pacific, Europe, the Middle East, Africa, North America, and South America is included in the study. For each of the six regions, the market size outlook by segments is forecast for 2030.
North America Transthyretin Amyloidosis Treatment Market Size Outlook- Companies plan for focused investments in a changing environment
The US continues to remain the market leader in North America, driven by a large consumer base, the presence of well-established providers, and a strong end-user industry demand. Leading companies focus on new product launches in the changing environment. The US economy is expected to grow in 2024 (around 2.2% growth in 2024), potentially driving demand for various Transthyretin Amyloidosis Treatment market segments. Similarly, Strong end-user demand is encouraging Canadian Transthyretin Amyloidosis Treatment companies to invest in niche segments. Further, as Mexico continues to strengthen its trade relations and invest in technological advancements, the Mexico Transthyretin Amyloidosis Treatment market is expected to experience significant expansion, offering lucrative opportunities for both domestic and international stakeholders.
Europe Transthyretin Amyloidosis Treatment Market Size Outlook-Companies investing in assessing consumers, categories, competitors, and capabilities
The German industry remains the major market for companies in the European Transthyretin Amyloidosis Treatment industry with consumers in Germany, France, the UK, Spain, Italy, and others anticipated to register a steady demand throughout the forecast period, driving the overall market prospects. In addition, the proactive approach of businesses in identifying and leveraging new growth prospects positions the European Transthyretin Amyloidosis Treatment market for an upward trajectory, fostering both domestic and international interest. Leading brands operating in the industry are emphasizing effective marketing strategies, innovative product offerings, and a keen understanding of consumer preferences.
Asia Pacific Transthyretin Amyloidosis Treatment Market Size Outlook- an attractive hub for opportunities for both local and global companies
The increasing prevalence of indications, robust healthcare expenditure, and increasing investments in healthcare infrastructure drive the demand for Transthyretin Amyloidosis Treatment in Asia Pacific. In particular, China, India, and South East Asian Transthyretin Amyloidosis Treatment markets present a compelling outlook for 2030, acting as a magnet for both domestic and multinational manufacturers seeking growth opportunities. Similarly, with a burgeoning population and a rising middle class, India offers a vast consumer market. Japanese and Korean companies are quickly aligning their strategies to navigate changes, explore new markets, and enhance their competitive edge. Our report utilizes in-depth interviews with industry experts and comprehensive data analysis to provide a comprehensive outlook of 6 major markets in the region.
Latin America Transthyretin Amyloidosis Treatment Market Size Outlook- Continued urbanization and rising income levels
Rising income levels contribute to greater purchasing power among consumers, spurring consumption and creating opportunities for market expansion. Continued urbanization and rising income levels are expected to sustainably drive consumption growth in the medium to long term.
Middle East and Africa Transthyretin Amyloidosis Treatment Market Size Outlook- continues its upward trajectory across segments
Robust demand from Middle Eastern countries including Saudi Arabia, the UAE, Qatar, Kuwait, and other GCC countries supports the overall Middle East Transthyretin Amyloidosis Treatment market potential. Fueled by increasing healthcare expenditure of individuals, growing population, and high prevalence across a few markets drives the demand for Transthyretin Amyloidosis Treatment.
Transthyretin Amyloidosis Treatment Market Company Profiles
The global Transthyretin Amyloidosis Treatment market is characterized by intense competitive conditions with leading companies opting for aggressive marketing to gain market shares. The report presents business descriptions, SWOT analysis, growth strategies, and financial profiles. Leading companies included in the study are Acrotech Biopharma, Alnylam Pharmaceuticals Inc, Astellas Pharma Inc, AstraZeneca, BridgeBio Pharma Inc, Bristol-Myers Squibb Company, Ionis Pharmaceuticals Inc, Johnson & Johnson Services Inc, Pfizer Inc, Prothena, SOM Biotech
Recent Transthyretin Amyloidosis Treatment Market Developments
The global Transthyretin Amyloidosis Treatment market study presents recent market news and developments including new product launches, mergers, acquisitions, expansions, product approvals, and other updates in the industry.
Transthyretin Amyloidosis Treatment Market Report Scope
Parameters: Revenue, Volume Price
Study Period: 2023 (Base Year); 2018- 2023 (Historic Period); 2024- 2030 (Forecast Period)
Currency: USD; (Upon request, can be provided in Euro, JPY, GBP, and other Local Currency)
Qualitative Analysis
- Pricing Analysis
- Value Chain Analysis
- SWOT Profile
- Market Dynamics- Trends, Drivers, Challenges
- Porter’s Five Forces Analysis
- Macroeconomic Impact Analysis
- Case Scenarios- Low, Base, High
By Treatment Therapy
Targeted Therapy
-Onpattro
-Inotersen
-Vyndaqel/Vyndamax
Supportive Therapy
Pipeline Therapy
By Type
ATTR-PN
ATTR-CM
By Disease Type
Hereditary Transthyretin Amyloidosis
-Polyneuropathy
-Cardiomyopathy
-Mixed Type
Wild Type Amyloidosis
By Distribution Channel
Hospital Pharmacies
Specialty Pharmacies
Retail Pharmacies
Online Pharmacies
Geographical Segmentation:
- North America (3 markets)
- Europe (6 markets)
- Asia Pacific (6 markets)
- Latin America (3 markets)
- Middle East Africa (5 markets)
Acrotech Biopharma
Alnylam Pharmaceuticals Inc
Astellas Pharma Inc
AstraZeneca
BridgeBio Pharma Inc
Bristol-Myers Squibb Company
Ionis Pharmaceuticals Inc
Johnson & Johnson Services Inc
Pfizer Inc
Prothena
SOM Biotech
Formats Available: Excel, PDF, and PPT
1. EXECUTIVE SUMMARY
1.1 Transthyretin Amyloidosis Treatment Market Overview and Key Findings, 2024
1.2 Transthyretin Amyloidosis Treatment Market Size and Growth Outlook, 2021- 2030
1.3 Transthyretin Amyloidosis Treatment Market Growth Opportunities to 2030
1.4 Key Transthyretin Amyloidosis Treatment Market Trends and Challenges
1.4.1 Transthyretin Amyloidosis Treatment Market Drivers and Trends
1.4.2 Transthyretin Amyloidosis Treatment Market Challenges
1.5 Competitive Landscape and Key Players
1.6 Competitive Analysis- Growth Strategies Adopted by Leading Transthyretin Amyloidosis Treatment Companies
2. TRANSTHYRETIN AMYLOIDOSIS TREATMENT MARKET SIZE OUTLOOK TO 2030
2.1 Transthyretin Amyloidosis Treatment Market Size Outlook, USD Million, 2021- 2030
2.2 Transthyretin Amyloidosis Treatment Incremental Market Growth Outlook, %, 2021- 2030
2.3 Segment Snapshot, 2024
3. TRANSTHYRETIN AMYLOIDOSIS TREATMENT MARKET- STRATEGIC ANALYSIS REVIEW
3.1 Porter's Five Forces Analysis
* Threat of New Entrants
* Threat of Substitutes
* Intensity of Competitive Rivalry
* Bargaining Power of Buyers
* Bargaining Power of Suppliers
3.2 Value Chain Analysis
3.3 SWOT Analysis
4. TRANSTHYRETIN AMYLOIDOSIS TREATMENT MARKET SEGMENTATION ANALYSIS AND OUTLOOK
4.1 Market Segmentation and Scope
4.2 Market Breakdown by Type, Application, and Other Segments, 2021-2030
By Treatment Therapy
Targeted Therapy
-Onpattro
-Inotersen
-Vyndaqel/Vyndamax
Supportive Therapy
Pipeline Therapy
By Type
ATTR-PN
ATTR-CM
By Disease Type
Hereditary Transthyretin Amyloidosis
-Polyneuropathy
-Cardiomyopathy
-Mixed Type
Wild Type Amyloidosis
By Distribution Channel
Hospital Pharmacies
Specialty Pharmacies
Retail Pharmacies
Online Pharmacies
4.3 Growth Prospects and Niche Opportunities, 2023- 2030
4.4 Regional comparison of Market Growth, CAGR, 2023-2030
5. REGION-WISE MARKET OUTLOOK TO 2030
5.1 Key Findings for Asia Pacific Transthyretin Amyloidosis Treatment Market, 2025
5.2 Asia Pacific Transthyretin Amyloidosis Treatment Market Size Outlook by Type, 2021- 2030
5.3 Asia Pacific Transthyretin Amyloidosis Treatment Market Size Outlook by Application, 2021- 2030
5.4 Key Findings for Europe Transthyretin Amyloidosis Treatment Market, 2025
5.5 Europe Transthyretin Amyloidosis Treatment Market Size Outlook by Type, 2021- 2030
5.6 Europe Transthyretin Amyloidosis Treatment Market Size Outlook by Application, 2021- 2030
5.7 Key Findings for North America Transthyretin Amyloidosis Treatment Market, 2025
5.8 North America Transthyretin Amyloidosis Treatment Market Size Outlook by Type, 2021- 2030
5.9 North America Transthyretin Amyloidosis Treatment Market Size Outlook by Application, 2021- 2030
5.10 Key Findings for South America Transthyretin Amyloidosis Treatment Market, 2025
5.11 South America Pacific Transthyretin Amyloidosis Treatment Market Size Outlook by Type, 2021- 2030
5.12 South America Transthyretin Amyloidosis Treatment Market Size Outlook by Application, 2021- 2030
5.13 Key Findings for Middle East and Africa Transthyretin Amyloidosis Treatment Market, 2025
5.14 Middle East Africa Transthyretin Amyloidosis Treatment Market Size Outlook by Type, 2021- 2030
5.15 Middle East Africa Transthyretin Amyloidosis Treatment Market Size Outlook by Application, 2021- 2030
6. COUNTRY-WISE MARKET SIZE OUTLOOK TO 2030
6.1 US Transthyretin Amyloidosis Treatment Market Size Outlook and Revenue Growth Forecasts
6.2 US Transthyretin Amyloidosis Treatment Industry Drivers and Opportunities
6.3 Canada Market Size Outlook and Revenue Growth Forecasts
6.4 Canada Transthyretin Amyloidosis Treatment Industry Drivers and Opportunities
6.6 Mexico Market Size Outlook and Revenue Growth Forecasts
6.6 Mexico Transthyretin Amyloidosis Treatment Industry Drivers and Opportunities
6.7 Germany Market Size Outlook and Revenue Growth Forecasts
6.8 Germany Transthyretin Amyloidosis Treatment Industry Drivers and Opportunities
6.9 France Market Size Outlook and Revenue Growth Forecasts
6.10 France Transthyretin Amyloidosis Treatment Industry Drivers and Opportunities
6.11 UK Market Size Outlook and Revenue Growth Forecasts
6.12 UK Transthyretin Amyloidosis Treatment Industry Drivers and Opportunities
6.13 Spain Market Size Outlook and Revenue Growth Forecasts
6.14 Spain Transthyretin Amyloidosis Treatment Industry Drivers and Opportunities
6.16 Italy Market Size Outlook and Revenue Growth Forecasts
6.16 Italy Transthyretin Amyloidosis Treatment Industry Drivers and Opportunities
6.17 Rest of Europe Market Size Outlook and Revenue Growth Forecasts
6.18 Rest of Europe Transthyretin Amyloidosis Treatment Industry Drivers and Opportunities
6.19 China Market Size Outlook and Revenue Growth Forecasts
6.20 China Transthyretin Amyloidosis Treatment Industry Drivers and Opportunities
6.21 India Market Size Outlook and Revenue Growth Forecasts
6.22 India Transthyretin Amyloidosis Treatment Industry Drivers and Opportunities
6.23 Japan Market Size Outlook and Revenue Growth Forecasts
6.24 Japan Transthyretin Amyloidosis Treatment Industry Drivers and Opportunities
6.26 South Korea Market Size Outlook and Revenue Growth Forecasts
6.26 South Korea Transthyretin Amyloidosis Treatment Industry Drivers and Opportunities
6.27 Australia Market Size Outlook and Revenue Growth Forecasts
6.28 Australia Transthyretin Amyloidosis Treatment Industry Drivers and Opportunities
6.29 South East Asia Market Size Outlook and Revenue Growth Forecasts
6.30 South East Asia Transthyretin Amyloidosis Treatment Industry Drivers and Opportunities
6.31 Rest of Asia Pacific Market Size Outlook and Revenue Growth Forecasts
6.32 Rest of Asia Pacific Transthyretin Amyloidosis Treatment Industry Drivers and Opportunities
6.33 Brazil Market Size Outlook and Revenue Growth Forecasts
6.34 Brazil Transthyretin Amyloidosis Treatment Industry Drivers and Opportunities
6.36 Argentina Market Size Outlook and Revenue Growth Forecasts
6.36 Argentina Transthyretin Amyloidosis Treatment Industry Drivers and Opportunities
6.37 Rest of South America Market Size Outlook and Revenue Growth Forecasts
6.38 Rest of South America Transthyretin Amyloidosis Treatment Industry Drivers and Opportunities
6.39 Middle East Market Size Outlook and Revenue Growth Forecasts
6.40 Middle East Transthyretin Amyloidosis Treatment Industry Drivers and Opportunities
6.41 Africa Market Size Outlook and Revenue Growth Forecasts
6.42 Africa Transthyretin Amyloidosis Treatment Industry Drivers and Opportunities
7. TRANSTHYRETIN AMYLOIDOSIS TREATMENT MARKET OUTLOOK ACROSS SCENARIOS
7.1 Low Growth Case
7.2 Reference Growth Case
7.3 High Growth Case
8. TRANSTHYRETIN AMYLOIDOSIS TREATMENT COMPANY PROFILES
8.1 Profiles of Leading Transthyretin Amyloidosis Treatment Companies in the Market
8.2 Business Descriptions, SWOT Analysis, and Growth Strategies
8.3 Financial Performance and Key Metrics
Acrotech Biopharma
Alnylam Pharmaceuticals Inc
Astellas Pharma Inc
AstraZeneca
BridgeBio Pharma Inc
Bristol-Myers Squibb Company
Ionis Pharmaceuticals Inc
Johnson & Johnson Services Inc
Pfizer Inc
Prothena
SOM Biotech
9. APPENDIX
9.1 Scope of the Report
9.2 Research Methodology and Data Sources
9.3 Glossary of Terms
9.4 Market Definitions
9.5 Contact Information
1.1 Transthyretin Amyloidosis Treatment Market Overview and Key Findings, 2024
1.2 Transthyretin Amyloidosis Treatment Market Size and Growth Outlook, 2021- 2030
1.3 Transthyretin Amyloidosis Treatment Market Growth Opportunities to 2030
1.4 Key Transthyretin Amyloidosis Treatment Market Trends and Challenges
1.4.1 Transthyretin Amyloidosis Treatment Market Drivers and Trends
1.4.2 Transthyretin Amyloidosis Treatment Market Challenges
1.5 Competitive Landscape and Key Players
1.6 Competitive Analysis- Growth Strategies Adopted by Leading Transthyretin Amyloidosis Treatment Companies
2. TRANSTHYRETIN AMYLOIDOSIS TREATMENT MARKET SIZE OUTLOOK TO 2030
2.1 Transthyretin Amyloidosis Treatment Market Size Outlook, USD Million, 2021- 2030
2.2 Transthyretin Amyloidosis Treatment Incremental Market Growth Outlook, %, 2021- 2030
2.3 Segment Snapshot, 2024
3. TRANSTHYRETIN AMYLOIDOSIS TREATMENT MARKET- STRATEGIC ANALYSIS REVIEW
3.1 Porter's Five Forces Analysis
* Threat of New Entrants
* Threat of Substitutes
* Intensity of Competitive Rivalry
* Bargaining Power of Buyers
* Bargaining Power of Suppliers
3.2 Value Chain Analysis
3.3 SWOT Analysis
4. TRANSTHYRETIN AMYLOIDOSIS TREATMENT MARKET SEGMENTATION ANALYSIS AND OUTLOOK
4.1 Market Segmentation and Scope
4.2 Market Breakdown by Type, Application, and Other Segments, 2021-2030
By Treatment Therapy
Targeted Therapy
-Onpattro
-Inotersen
-Vyndaqel/Vyndamax
Supportive Therapy
Pipeline Therapy
By Type
ATTR-PN
ATTR-CM
By Disease Type
Hereditary Transthyretin Amyloidosis
-Polyneuropathy
-Cardiomyopathy
-Mixed Type
Wild Type Amyloidosis
By Distribution Channel
Hospital Pharmacies
Specialty Pharmacies
Retail Pharmacies
Online Pharmacies
4.3 Growth Prospects and Niche Opportunities, 2023- 2030
4.4 Regional comparison of Market Growth, CAGR, 2023-2030
5. REGION-WISE MARKET OUTLOOK TO 2030
5.1 Key Findings for Asia Pacific Transthyretin Amyloidosis Treatment Market, 2025
5.2 Asia Pacific Transthyretin Amyloidosis Treatment Market Size Outlook by Type, 2021- 2030
5.3 Asia Pacific Transthyretin Amyloidosis Treatment Market Size Outlook by Application, 2021- 2030
5.4 Key Findings for Europe Transthyretin Amyloidosis Treatment Market, 2025
5.5 Europe Transthyretin Amyloidosis Treatment Market Size Outlook by Type, 2021- 2030
5.6 Europe Transthyretin Amyloidosis Treatment Market Size Outlook by Application, 2021- 2030
5.7 Key Findings for North America Transthyretin Amyloidosis Treatment Market, 2025
5.8 North America Transthyretin Amyloidosis Treatment Market Size Outlook by Type, 2021- 2030
5.9 North America Transthyretin Amyloidosis Treatment Market Size Outlook by Application, 2021- 2030
5.10 Key Findings for South America Transthyretin Amyloidosis Treatment Market, 2025
5.11 South America Pacific Transthyretin Amyloidosis Treatment Market Size Outlook by Type, 2021- 2030
5.12 South America Transthyretin Amyloidosis Treatment Market Size Outlook by Application, 2021- 2030
5.13 Key Findings for Middle East and Africa Transthyretin Amyloidosis Treatment Market, 2025
5.14 Middle East Africa Transthyretin Amyloidosis Treatment Market Size Outlook by Type, 2021- 2030
5.15 Middle East Africa Transthyretin Amyloidosis Treatment Market Size Outlook by Application, 2021- 2030
6. COUNTRY-WISE MARKET SIZE OUTLOOK TO 2030
6.1 US Transthyretin Amyloidosis Treatment Market Size Outlook and Revenue Growth Forecasts
6.2 US Transthyretin Amyloidosis Treatment Industry Drivers and Opportunities
6.3 Canada Market Size Outlook and Revenue Growth Forecasts
6.4 Canada Transthyretin Amyloidosis Treatment Industry Drivers and Opportunities
6.6 Mexico Market Size Outlook and Revenue Growth Forecasts
6.6 Mexico Transthyretin Amyloidosis Treatment Industry Drivers and Opportunities
6.7 Germany Market Size Outlook and Revenue Growth Forecasts
6.8 Germany Transthyretin Amyloidosis Treatment Industry Drivers and Opportunities
6.9 France Market Size Outlook and Revenue Growth Forecasts
6.10 France Transthyretin Amyloidosis Treatment Industry Drivers and Opportunities
6.11 UK Market Size Outlook and Revenue Growth Forecasts
6.12 UK Transthyretin Amyloidosis Treatment Industry Drivers and Opportunities
6.13 Spain Market Size Outlook and Revenue Growth Forecasts
6.14 Spain Transthyretin Amyloidosis Treatment Industry Drivers and Opportunities
6.16 Italy Market Size Outlook and Revenue Growth Forecasts
6.16 Italy Transthyretin Amyloidosis Treatment Industry Drivers and Opportunities
6.17 Rest of Europe Market Size Outlook and Revenue Growth Forecasts
6.18 Rest of Europe Transthyretin Amyloidosis Treatment Industry Drivers and Opportunities
6.19 China Market Size Outlook and Revenue Growth Forecasts
6.20 China Transthyretin Amyloidosis Treatment Industry Drivers and Opportunities
6.21 India Market Size Outlook and Revenue Growth Forecasts
6.22 India Transthyretin Amyloidosis Treatment Industry Drivers and Opportunities
6.23 Japan Market Size Outlook and Revenue Growth Forecasts
6.24 Japan Transthyretin Amyloidosis Treatment Industry Drivers and Opportunities
6.26 South Korea Market Size Outlook and Revenue Growth Forecasts
6.26 South Korea Transthyretin Amyloidosis Treatment Industry Drivers and Opportunities
6.27 Australia Market Size Outlook and Revenue Growth Forecasts
6.28 Australia Transthyretin Amyloidosis Treatment Industry Drivers and Opportunities
6.29 South East Asia Market Size Outlook and Revenue Growth Forecasts
6.30 South East Asia Transthyretin Amyloidosis Treatment Industry Drivers and Opportunities
6.31 Rest of Asia Pacific Market Size Outlook and Revenue Growth Forecasts
6.32 Rest of Asia Pacific Transthyretin Amyloidosis Treatment Industry Drivers and Opportunities
6.33 Brazil Market Size Outlook and Revenue Growth Forecasts
6.34 Brazil Transthyretin Amyloidosis Treatment Industry Drivers and Opportunities
6.36 Argentina Market Size Outlook and Revenue Growth Forecasts
6.36 Argentina Transthyretin Amyloidosis Treatment Industry Drivers and Opportunities
6.37 Rest of South America Market Size Outlook and Revenue Growth Forecasts
6.38 Rest of South America Transthyretin Amyloidosis Treatment Industry Drivers and Opportunities
6.39 Middle East Market Size Outlook and Revenue Growth Forecasts
6.40 Middle East Transthyretin Amyloidosis Treatment Industry Drivers and Opportunities
6.41 Africa Market Size Outlook and Revenue Growth Forecasts
6.42 Africa Transthyretin Amyloidosis Treatment Industry Drivers and Opportunities
7. TRANSTHYRETIN AMYLOIDOSIS TREATMENT MARKET OUTLOOK ACROSS SCENARIOS
7.1 Low Growth Case
7.2 Reference Growth Case
7.3 High Growth Case
8. TRANSTHYRETIN AMYLOIDOSIS TREATMENT COMPANY PROFILES
8.1 Profiles of Leading Transthyretin Amyloidosis Treatment Companies in the Market
8.2 Business Descriptions, SWOT Analysis, and Growth Strategies
8.3 Financial Performance and Key Metrics
Acrotech Biopharma
Alnylam Pharmaceuticals Inc
Astellas Pharma Inc
AstraZeneca
BridgeBio Pharma Inc
Bristol-Myers Squibb Company
Ionis Pharmaceuticals Inc
Johnson & Johnson Services Inc
Pfizer Inc
Prothena
SOM Biotech
9. APPENDIX
9.1 Scope of the Report
9.2 Research Methodology and Data Sources
9.3 Glossary of Terms
9.4 Market Definitions
9.5 Contact Information
